Neuronal ApoE upregulates MHC-I expression to drive selective neurodegeneration in Alzheimer's disease

Selective neurodegeneration is a critical causal factor in Alzheimer's disease. Zalocusky et al. demonstrate a causal chain linking neuronal ApoE expression to MHC-I expression and, subsequently, to tau pathology and selective neurodegeneration. Selective neurodegeneration is a critical causal factor in Alzheimer's disease (AD); however, the mechanisms that lead some neurons to perish, whereas others remain resilient, are unknown. We sought potential drivers of this selective vulnerability using single-nucleus RNA sequencing and discovered that ApoE expression level is a substantial driver of neuronal variability. Strikingly, neuronal expression of ApoE-which has a robust genetic linkage to AD-correlated strongly, on a cell-by-cell basis, with immune response pathways in neurons in the brains of wild-type mice, human ApoE knock-in mice and humans with or without AD. Elimination or over-expression of neuronal ApoE revealed a causal relationship among ApoE expression, neuronal MHC-I expression, tau pathology and neurodegeneration. Functional reduction of MHC-I ameliorated tau pathology in ApoE4-expressing primary neurons and in mouse hippocampi expressing pathological tau. These findings suggest a mechanism linking neuronal ApoE expression to MHC-I expression and, subsequently, to tau pathology and selective neurodegeneration.

Automated summary

Selective neurodegeneration is a critical causal factor in Alzheimer's disease, and a study has demonstrated a causal relationship between neuronal ApoE expression and MHC-I expression leading to tau pathology and selective neurodegeneration. The correlation between ApoE expression and immune response pathways suggests a mechanism for the vulnerability of certain neurons in Alzheimer's disease.